Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Institute of Cancer Research

Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery

Durvalumab shows promising results in trial led by London-based Institute of Cancer Research

The Guardian - UK

Three-drug therapy ‘doubles breast cancer survival time without progression’

The trial included 325 patients from across 28 countries.

Evening Standard

Breakthrough reverses prostate cancer’s resistance to treatment

Researchers said their discovery is ‘tremendously exciting’.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Gerry Potter obituary

Other lives: Medicinal chemist and co-creator of one of the most widely used drugs for prostate cancer

The Guardian - UK

Gene test could guide use of chemotherapy in bowel cancer patients

Scientists have found that patients respond differently to drugs based on a mutation in a gene called KRAS.

The Independent UK

Bowel cancer breakthrough as scientists find chemotherapy response could be predicted by existing NHS test

Researchers hope KRAS test can serve renewed function as soon as possible

The Independent UK

Population-wide gene testing ‘limited in its ability to predict disease risk’

Experts say polygenic risk scoring fails to take into other factors that contribute to disease risk, such as smoking or deprivation.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Radiotherapy measured against surgery for prostate cancer treatment side effects

Intensive radiotherpay has some advantages and disadvantages when compared to an operation.

The Independent UK

London honours cancer scientists for historic research breakthrough

Commemorative plaques have been installed at labs belonging to The Institute of Cancer Research in Chelsea and Sutton

Evening Standard

London doctors use ‘Man Van’ to help speed up prostate cancer detection

The mobile clinic has been driven to construction sites and GP surgeries, offering rapid testing

Evening Standard

'Electrical signals in breasts could help us understand why cancer spreads - and stop it'

Dr Miriam Stoppard shares exciting research from Imperial College London on the electrical charges given out by cancer cells, which could lead to targeted attacks and new treatments

Daily Mirror

Daniel Catovsky obituary

Other lives: Blood cancer specialist who helped to develop treatments for various types of leukaemia

The Guardian - UK

Breast cancer patients start proton beam therapy trial

Proton beam therapy is significantly more expensive compared to standard radiotherapy

Wales Online

'I noticed painful twinges in my breast... now I'm taking part in a UK-first trial at the Christie Hospital'

Kim Jones, 44, was diagnosed with breast cancer in February and has now been selected for a pioneering trial in Manchester

Manchester Evening News

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Trial to see if precision proton beam therapy can benefit breast cancer patients

It is hoped the move could benefit a small number of patients who may have complications from traditional radiotherpay treatment.

The Independent UK

Covid could help to cure cancer, new research reveals

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

The Independent UK

Cancer vaccine halves risk of relapse or death using Covid jab technology

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

Daily Mirror

Survival rates for advanced cancer could double in next decade thanks to breakthrough

The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust says there is hope for those with advanced cancer thanks to new breakthroughs and research

Get all your
news in one place.

100's of premium titles.
One news app.

Dynamite News

Health: Researchers find immunotherapies for chemotherapy-resistant breast tumour

The researchers have identified immune cell types that could be targeted to create particular immunotherapies for chemotherapy-resistant breast tumours. Read more on Dynamite News

Daily Mirror

Dame Deborah James’ dad pays tribute as late daughter awarded honorary degree

Dame Deborah James, who passed away in June, has been awarded an honorary degree from the Institute of Cancer Research, with her dad paying a sweet tribute at the ceremony

The Independent UK

Life-extending prostate cancer drug rejected for NHS

The Institute of Cancer Research in London said the decision means men will miss out on a highly innovative treatment.

Daily Record

Terminal cancer patients could be helped by drug that stops growth of disease

Experts say the cancer treatment could be an effective tool against different forms of the disease.

The Guardian - UK

New cancer treatment offers hope to patients out of options

Exclusive: UK trial finds finds combination of drugs can work where tumours have become resistant to immunotherapy

Daily Mirror

'Junk' genes could be causing cell mutations that lead to cancer, study claims

Half of our DNA genetic code was previously thought to be useless 'junk' DNA, but cancer researchers believe it could be the cause of the mutations that lead to cancer.

The Guardian - UK

Research on ‘molecular drills’ of skin cancer cells offers hope for treatment

Institute of Cancer Research in London isolates gene that allows melanoma cells to spread

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

University of Cambridge

The Institute of Cancer Research

Institute of Cancer Research

26 stories

The Royal Marsden NHS Foundation Trust

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.